Skip to main content
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD logo

BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD — Investor Relations & Filings

Ticker · 000931 ISIN · CNE000001030 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 3,000 across all filing types
Latest filing 2026-06-03 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 000931

About BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD

https://www.centek.com.cn

Beijing Centergate Technologies (Holding) Co., Ltd. focuses on the research, development, production, and distribution of medical and healthcare products. The company’s core operations involve the manufacturing of chemical pharmaceuticals, traditional Chinese medicines, and health supplements. Its product portfolio addresses various therapeutic areas, including cardiovascular health, digestive system treatments, and anti-infective therapies. Additionally, the company provides healthcare services and develops medical devices. Through its specialized subsidiaries, it maintains integrated research and manufacturing capabilities aimed at providing clinical solutions and health management products. The organization emphasizes technological advancement and quality control across its supply chain to meet diverse patient needs and healthcare standards.

Recent filings

Filing Released Lang Actions
2025年度利润分配实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled “2025年度利润分配实施公告” and provides detailed notice of dividend distribution amounts, record date, ex-dividend date, tax arrangements, payment method, and related resolutions. This matches the definition of a Notice of Dividend Amount (DIV).
2026-06-03 Chinese
关于下属公司涉及诉讼的公告
Legal Proceedings Report Classification · 90% confidence The document is a formal announcement by Beijing Zhongguancun Technology Development (Holding) Co., Ltd. disclosing details of a significant litigation involving its subsidiary, including case background, claims, court decisions, potential impacts, and related pleadings. It is clearly a legal proceedings report rather than an earnings release, management guidance, or investor presentation. Therefore, it fits the “Legal Proceedings Report” category.
2026-05-15 Chinese
关于持股5%以上股东持股比例触及5%整数倍和1%整数倍暨披露简式权益变动报告书的提示性公告
Major Shareholding Notification Classification · 92% confidence The document is a formal announcement and simplified equity change report (“简式权益变动报告书”) detailing how a >5% shareholder’s stake crossed integer thresholds and the resulting shareholding percentages. It provides comprehensive tables of shareholding changes by major shareholders. This exactly matches a Major Shareholding Notification.
2026-05-14 Chinese
简式权益变动报告书（黄光裕、国美控股集团有限公司、国美电器有限公司）
Major Shareholding Notification Classification · 89% confidence The document is a “简式权益变动报告书” (Simplified Equity Change Report) issued by controlling shareholders and related persons describing passive share reductions, breaking of concerted action relationships, and detailed pre- and post-transaction holdings. It is not an earnings release, financial report, or announcement of a report. Rather it is a mandatory disclosure of significant shareholding changes by major shareholders (crossing thresholds and detailing share count changes). This aligns with a Major Shareholding Notification (MRQ).
2026-05-14 Chinese
关于下属公司多多药业非布司他片获得《药品注册证书》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the approval and issuance of a drug registration certificate for a subsidiary company's pharmaceutical product. It details the certificate number, drug specifications, regulatory approval, and potential impact on the company. The document is relatively short (1647 characters) and serves as a formal notification to shareholders and the public about this regulatory milestone. It does not contain financial statements, management discussion, or detailed financial data. It is not a full report but an official announcement of a regulatory approval event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-08 Chinese
关于下属公司山东华素健康护理品公司取得实用新型专利证书的公告
Regulatory Filings Classification · 93% confidence The document is an official announcement by the company regarding its subsidiary obtaining a utility model patent certificate from the National Intellectual Property Administration. It does not pertain to financial results, capital changes, dividends, board changes, securities transactions, or any specialized category. Therefore, it falls under general regulatory announcements.
2026-04-14 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.